detected at low levels and correlated positively with PVL. In addition, HAM/TSP patients and ACs with high PVL expressed higher levels of IFN-γ mRNA in comparison to IL-10, while ACs with low PVL presented an equilibrate IFN-γ/IL-10 ratio. Conclusions: The presence of large persistent HTLV-1-infected clones in association with viral gene expression, even at small levels, could stimulate the intense inflammatory response in HTLV-1-infected individuals. This was supported by a high ratio of IFN-γ/IL-10 relative expression in HAM/TSP patients and ACs with high PVL, indicating that these parameters could aid the identification of ACs with a high risk to develop HAM/TSP.
ated myelopathy/tropical spastic paraparesis (HAM/TSP) [2] . In contrast, most HTLV-1-infected individuals will remain asymptomatic carriers (ACs) throughout life [2] .
HAM/TSP is a demyelinating disease of the spinal cord that initiates as an inflammatory reaction after blood-brain barrier disruption. The immune response is mediated by cytotoxic T lymphocytes (CTLs) against HTLV-1-infected T cells in the central nervous system, resulting in exacerbated production of Th1 cytokines by activated cells, such as IFN-γ and TNF-α, which induces the death of central nervous system cells [2, 3] . However, the events or mechanisms that disrupt the asymptomatic condition in HTLV-1 infection and triggers HAM/TSP development are still unknown. It has been shown that high HTLV-1 proviral load (PVL) in peripheral blood is a risk factor for neurological involvement [4] .
It has been demonstrated that HTLV-1-infected T-cell clones can persist for many years in patients [5, 6] , and infected individuals generally carry 500-5,000 distinct infected T-cell clones defined by proviral integration sites [7] . Indeed, clonal expansion of infected cells is responsible for maintaining HTLV-1 PVL levels [8] . In contrast, infected individuals show a chronic and intense response of activated HTLV-1-specific CTLs, which is elicited by persistent expression of viral antigens [9, 10] . Therefore, expression of HTLV-1 proteins, notably Tax protein, influences both the proliferation of infected cells as their susceptibility to lysis by CTLs [8] .
HTLV-1 Tax transactivator protein interacts with different transcription factors, including CREB/ATF, SRF, NFAT, and NF-κB [11, 12] , thereby regulating the expression of viral genes and the function of different cellular processes, such as cell proliferation, differentiation and death, cytoskeleton reorganization, and DNA repair [13] [14] [15] [16] . HTLV-1 provirus also presents an antisense gene coding for a negative regulator of Tax functions, denominated HBZ (HTLV-1 basic leucine zipper factor) [17] . HBZ partially represses Tax activity through the competition for association with transcription factors such as CREB [18] , CREB-2 [17] , and AP-1 [19, 20] , and it is important in survival of HTLV-1-transformed cells [21] and in enhancement of in vivo infectivity [22] .
Usually, a long interval elapses from the time of infection to disease onset in HTLV-1 carriers, ranging from 20 to 30 years [2] . The development of markers to assist the early identification of HTLV-1 ACs at a higher risk to develop HAM/TSP would allow better clinical monitoring and implementation of therapeutic interventions to delay disease progression. Therefore, we examined the profiles of IFN-γ and IL-10 mRNA expression and parameters of HTLV-1 infection, such as PVL levels, the relative expression of viral tax and HBZ genes, and the pattern of provirus integration sites, in ACs and HAM/TSP patients, to determine biological markers for development of HAM/TSP.
Materials and Methods

Patients and Samples
The study was conducted at the Instituto Nacional de Infectologia Evandro Chagas (INI/FIOCRUZ), with approval of the Research Ethics Committee of the INI/FIOCRUZ (CAAE 0013.0.009.000-07) from 2009 to 2013. Forty-six HTLV-1-infected individuals (21 ACs and 25 HAM/TSP patients) and 12 healthy donors (HDs) were enrolled. After informed consent, peripheral blood was collected in tubes with EDTA or heparin. PBMCs were obtained by centrifugation of heparinized blood on Histopaque 1077 (Sigma-Aldrich), and cells were counted in automatic cell counter (XT1800i, Symex). Cell suspensions were adjusted to 10 6 PBMCs/ml in RPMI-1640 supplemented with 10% FBS, and 10 7 cells were incubated without stimulation at 37° for 20 h in 5% CO 2 atmosphere. Fresh and cultured PBMCs were stored at -20° in Trizol reagent (Invitrogen) until use.
DNA Extraction and HTLV-1 PVL
DNA from EDTA peripheral blood was obtained using the Puregene Blood Core kit (Qiagen), following the manufacturer's instructions. HTLV-1 PVL was determined by real-time PCR using TaqMan probes in Smart Cycler II equipment (Cepheid), as previously described [23] . The gene for β-globin was used as a reference, and infected cells were detected by amplification of the HTLV-1 tax gene. Standard curves to determine the total number of leukocytes and the number of infected cells in reactions were constructed, respectively, with twofold dilutions of human genomic DNA (Promega) and DNA from the HTLV-1-infected TARL-2 cell line. PVL as the frequency of HTLV-1-infected cells in peripheral blood leukocytes was calculated as [(copy number of tax )/(copy number of β-globin/2)] ×100.
Amplification of HTLV-1 Integration Sites by Inverse Long-PCR
Integration sites of HTLV-1 provirus in host-cell DNA was evaluated by inverse long-PCR (IL-PCR), as described by Etoh et al. [5] . Initially, 1 μg of DNA from peripheral blood was digested with 5U Eco RI (New England Biolabs) at 37° for 2 h. Afterwards, DNA fragments (300 ng) were autocircularized overnight at 4° with 2 U T4 DNA ligase, in duplicate (New England Biolabs). After purification, circularized DNA was incubated overnight at 37° with 10 U Mlu I (New England Biolabs). After further purification, the samples were submitted to PCR with a GeneAmp XL PCR kit (Applied Biosystems), using 40 pmol of U3 and U5 LTR-directed primers, under the following amplification cycle: denaturation at 94° for 1 min, 37 cycles of denaturation at 94° for 1 min and annealing/ extension at 68° for 7 min, and final extension at 72° for 10 min. Amplicons were electrophoresed in a 1% agarose gel in 1× TBE buffer at 80 V for 3 h and DNA was stained with GelRed (Biotium). Oligoclonal integration was considered when 2-10 well-defined bands were observed and polyclonal integration was defined when only smear background or more than 10 bands were present. 
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RNA Extraction and Quantitative Reverse Transcription PCR for Gene Expression
Total RNA was extracted from fresh or cultured PBMCs using Trizol reagent, according to manufacturer's instructions, and was readily used for cDNA synthesis with SuperScript III (Invitrogen). Reverse transcription was performed with 2 μg of total RNA and random hexamers (Invitrogen) at 50° for 50 min, in a final volume of 20 μl. Relative expression of IFN-γ and IL-10 mRNAs and of viral tax and HBZ mRNAs was performed by quantitative PCR in Rotor-Gene Q equipment (Qiagen) using the Rotor Gene Probe PCR kit (Qiagen), with 100 ng of cDNA in a final volume of 25 μl, and GAPDH expression as a reference. The expression of GAPDH, IFN-γ, and IL-10 mRNAs was evaluated with predesigned TaqMan gene expression assays (Applied Biosystems), HTLV-1 tax cDNAs were amplified as described for PVL quantification, and HBZ expression was detected as previously described [24] . Duplicate reactions were submitted to: activation/denaturation at 95° for 3 min, 50 cycles of denaturation at 95° for 5 s, and annealing/extension at 60° for 15 s; fluorescence was detected at the end of each cycle. Relative gene expression was evaluated by the 2 − ΔΔCt method [25] .
Statistical Analysis
Graphs and statistical analysis were performed using GraphPad Prism 5. After defining the normal distribution of data by Kolmogorov-Smirnov test, parametric data were tested by Pearson correlation, ANOVA, and Student's t test, with Welch's correction when indicated. Nonparametric data were evaluated by Kruskal-Wallis and Mann-Whitney tests and Spearman correlation, and association between qualitative variables was tested by χ 2 or Fisher's exact test. Results with p < 0.05 were considered statistically significant.
Results
HTLV-1 Provirus Integration Pattern and Persistence of Infected Cell Clones
DNA samples from HAM/TSP patients (n = 6) and ACs (n = 5) with similar high PVL levels (HAM/TSP: 20.60 ± 15.31% and ACs: 12.35 ± 1.25%; p = 0.246, Student's t test with Welch's correction) obtained in two or three distinct periods with a mean interval of 36.4 months (95% CI: 23.1-49.7) between the first and last sample were used to evaluate HTLV-1 provirus integration by IL-PCR. Both HAM/TSP patients and ACs showed predominantly stochastic patterns of proviral integration. In IL-PCR, the amplification background in agarose gel electrophoresis represents minor clones, while clear bands are related to large HTLV-1-infected clonal populations ( fig. 1 a) . The integration profile was oligoclonal in all 6 HAM/TSP patients and in 3 of 5 ACs. Therefore, no association was observed between the integration pattern of HTLV-1 and the clinical condition of the evaluated subjects (p = 0.189, Fisher's exact test). On the other hand, chronic HAM/TSP patients (mean disease duration of 14 ± 8.1 years) presented higher frequency of large persistent HTLV-1-infected clones (5.82 ± 1.71 clones) compared to ACs (3.25 ± 1.72 clones; p = 0.046; fig. 1 b) . 
Expression of HTLV-1 tax and HBZ mRNAs in PBMCs from Infected Individuals
In the same way that chronic HAM/TSP patients exhibited higher PVL median than ACs [6.28% (95% CI: 7.24-13.11) and 4.31% (95% CI: 3.38-7.27), respectively, Mann-Whitney, p = 0.002] and higher frequency of large persistent HTLV-1-infected clonal populations ( fig. 1 b) , these individuals also showed higher relative expression of tax mRNAs by fresh PBMCs in comparison to ACs (p < 0.001; fig. 2 a) . However, the HTLV-1 tax gene was weakly expressed ex vivo. Expression of tax mRNAs was 10,000-100,000 times lower than basal cellular transcription levels defined by GAPDH expression. The expression of tax mRNAs was upregulated after overnight incubation of PBMCs without stimulation. However, statistically significant differences between ACs and HAM/TSP patients disappeared ( fig. 2 b) . On the other side, HBZ mRNA expression was evaluated only in PBMC incubated for 20 h without stimulation, because it is expressed at low levels. Although HBZ (2) fig. 2 c) , even when it was corrected with PVL levels (p = 0.594, Mann-Whitney).
IL-10 and IFN-γ mRNA Expression in PBMCs from HTLV-1-Infected Individuals
Differences in relative expression of IL-10 mRNAs were not observed between ACs and HAM/TSP patients (p = 0.717; fig. 2 d) . However, both ACs and HAM/TSP patients presented reduced IL-10 mRNA expression in comparison to uninfected individuals (p = 0.005 and p = 0.006, respectively). On the other hand, HAM/TSP patients showed increased levels of IFN-γ expression compared to ACs (p < 0.001) and HDs (p = 0.001; fig. 2 e) , but no differences were observed between ACs and HDs (p = 0.161). The ratio between IFN-γ and IL-10 mRNA relative expression levels was also investigated by calculating the -ΔCt (mean Ct IFN-γ -mean Ct IL-10 ) ( fig. 3 ) , taking that commercial realtime PCR for these genes presented similar efficiency rates. On average, HAM/TSP patients expressed more IFN-γ than IL-10 (-ΔCt = 5.10 or 34.30 times), while ACs presented balanced levels of expression of both cytokines ( − ΔCt = 0.27). In contrast, HDs expressed more IL-10 instead of IFN-γ (-ΔCt = -6.61 or 97.68 times). However, differences were statistically significant only in HAM/TSP patients ( fig. 3 ) .
Correlation between HTLV-1 PVL and Expression of Tax, HBZ, IL-10, and IFN-γ mRNAs
The expression of viral and cytokine mRNAs was also assessed according to HTLV-1 PVL levels. It was observed that expression of tax mRNAs in fresh PBMCs and Correlation between relative expression rates of tax, HBZ, IL-10, and IFN-γ mRNAs and HTLV-1 PVL levels in HTLV-1 ACs and in HAM/TSP patients was evaluated by Spearman correlation, and p < 0.05 was considered statistically significant. a R = Correlation coefficient of Spearman. 
Association between IFN-γ/IL-10 Expression Ratio and the Neurological Involvement
Since high HTLV-1 PVL has been associated with a higher chance of neurological involvement, HTLV-1-infected individuals were subdivided according to PVL levels: low (<5%) and high ( ≥ 5%). We observed that HAM/TSP patients with low PVL and ACs with high PVL presented an IFN-γ/IL-10 mRNA ratio tending towards zero, indicating that both cytokines are expressed in equivalent levels ( fig. 4 ) . These data suggest that ACs with high HTLV-1 PVL present an inflammatory profile similar to that of HAM/ TSP patients. On the other hand, HAM/TSP patients with high PVL presented higher levels of IFN-γ against IL-10, with median -ΔCt (IFN-γ -IL-10) significantly higher than ACs with low PVL (p = 0.002), which in turn expressed lower levels of IFN-γ ( fig. 4 ) . The ratio between IFN-γ and IL-10 mRNA expression did not correlate with HTLV-1 PVL levels in either ACs ( R 2 = 0.115; p = 0.199, Spearman correlation) or HAM/TSP patients ( R 2 = 0.078; p = 0.261, Spearman correlation). It was also an independent variable from PVL in the AC group (p = 0.315, Fisher's exact test). However, a high IFN-γ/IL-10 expression ratio was associated with neurological involvement in HTLV-1-infected individuals (p = 0.023 and OR = 8.00, χ 2 test; table 3 ).
Discussion
HAM/TSP is a slowly progressive incapacitating disease of lower limbs and usually presents an insidious onset [2] . It has been shown that HAM/TSP patients present higher HTLV-1 PVL levels than ACs, and therefore it has been proposed as a marker for monitoring evolution to disease [23] . Usually, it is observed that circulating HTLV-1-infected clones contain a single integrated proviral copy [26] , and PVL levels are maintained mainly through expansion of these cells [4] . We observed that both ACs and HAM/TSP patients with high HTLV-1 PVL presented large HTLV-1-infected clonal populations in peripheral blood, and some of them were capable of persisting over time, corroborating other reports [7, 26] . PVL levels have been associated with the number of HTLV-1-infected clones both in ACs and HAM/TSP patients, and HAM/ TSP patients present increased absolute numbers of HTLV-1-infected clones, which explain the higher PVL levels in these individuals [7] . However, PVL is achieved 112 by a dynamic process, involving the proliferation of infected cells and their elimination by immune responses. Therefore, within a relatively constant PVL level, it can become more oligoclonal over time. Thus, complementing these observations, we showed that large persistent infected clonal populations were at higher frequency in HAM/TSP patients than in ACs with similar PVL levels. It has been shown that in clones of equivalent abundance, integration sites in genes and active regions are more frequent in ACs than patients with HAM/TSP [27] , and thus more likely to express viral antigens. Therefore, the lower number of large HTLV-1-infected clones that we observed in ACs in comparison to HAM/TSP patients over time is probably associated with elimination of antigenexpressing infected cells by immune responses, which have been shown to be more effective in ACs than in HAM/TSP patients [4] .
We also observed that viral expression in vivo occurs at low levels, about 10,000-100,000 times lower than cellular GAPDH transcription rates. Furthermore, PBMCs from HAM/TSP patients presented higher expression of tax mRNAs in comparison to ACs, and this positively correlated with PVL. It is well known that incubation of infected cells without stimulation is sufficient to induce provirus expression. However, here we showed that in vivo differences between ACs and HAM/TSP patients were lost after cell incubation, and also the correlation with PVL considering the AC group. HBZ is fairly expressed in vivo, and we observed no significant differences in HBZ mRNA expression between ACs and HAM/TSP patients, probably due to incubation, although it positively correlated with PVL. Despite the strong CTL response commonly observed against the Tax protein, it has been shown that individuals presenting HLA class I alleles that strongly bind the HBZ protein have lower PVL levels and are more likely to persist asymptomatically due to effective responses of CD8+ T cells specific to HBZ [28] . Therefore, although the expression of HTLV-1 genes influence both proliferation of infected cells and their elimination by exposure to CTLs, the quality of the response appears to determine the outcome of disease. Therefore, we suggest that a higher frequency of large persistent HTLV-1-infected clonal populations would contribute to higher PVL levels usually observed in HAM/TSP patients. Furthermore, persistent expression of viral antigens, even at low concentrations, by infected cells would act as a constant stimulus for the chronic HTLV-1-specific CTL responses [9, 10] that are involved in HAM/TSP onset [2] .
It has been reported that HTLV-1 is characterized by a strong Th1 response [29] , and PBMCs from HAM/TSP patients secrete high levels of IL-2 and IFN-γ in vitro compared to ACs [30] . Moreover, it has been demonstrated that HAM/TSP patients also present a high frequency of CD4 + IFN-γ + T cells that positively correlates with HTLV-1 PVL [31, 32] . We also found that PBMCs from HAM/TSP patients presented increased levels of IFN-γ mRNAs in comparison to both ACs and HDs. Furthermore, induction of IFN-γ gene expression was directly related to infection because it positively correlated to PVL at least in HAM/TSP patients. In contrast, no significant differences in expression of IL-10 mRNAs were observed between ACs and HAM/TSP patients. Our observations are in agreement with other reports in which differences in levels of IL-10 mRNA expression were not evidenced between ACs and HAM/TSP patients in vitro [33] , in serum samples [34] , or in cerebrospinal fluid [35] . However, unlike recent published data [34] , we showed that PBMCs from HTLV-1-infected individuals, regardless of neurological condition, expressed significantly lower IL-10 mRNA levels than healthy subjects. This difference probably relies on distinct methods to address IL-10 expression since previous findings represented the quantification of cytokine protein levels in serum, in contrast to our data from mRNA expression. Since IFN-γ is associated with inflammatory conditions and we observed an inversely proportional tendency between HTLV-1 PVL and the expression levels of the immunosuppressive IL-10 cytokine, which suggests that this cytokine could influence the maintenance of asymptomatic status, we evaluated the ratio between IFN-γ and IL-10 mRNA relative expression. In this context, we observed three distinct patterns: (1) uninfected individuals with significantly higher levels of IL-10 than IFN-γ, (2) HTLV-1 ACs with equivalent mean mRNA levels of IFN-γ and IL-10, and (3) HAM/TSP patients with higher expression levels of IFN-γ in comparison to IL-10.
Hence, since HAM/TSP patients present higher PVL levels than AC and it has been associated with an increased risk for neurological involvement [23] , and IFN-γ gene expression correlated with PVL, we assessed the association between the inflammatory status defined by the ratio between IFN-γ and IL-10 mRNA relative expression and the neurological condition in HTLV-1-infected individuals according to low or high HTLV-1 PVL levels. We identified distinct patterns, in which HTLV-1-infected subjects expressing higher levels of IFN-γ than IL-10 were 8 times more likely to present HAM/TSP, demonstrating that a proinflammatory condition is a characteristic factor of the immunological profile of these patients. In addition, we observed that ACs tend to present higher IFN-γ expression rates than uninfected individuals, although it was not statistically significant. This indicates that despite the lack of disease manifestation, these individuals present slight signs of inflammation but less striking than in HAM/TSP patients.
In addition, ACs with high PVL presented inflammatory profiles similar to HAM/TSP patients, in accordance to previous studies [36, 37] , but only to HAM/TSP patients with low PVL, indicating that factors other than PVL are involved in disease outcome. Since not all HAM/ TSP patients present high PVL, the additional evaluation of the inflammatory profile considering the ratio between IFN-γ and IL-10 mRNA expression could aid the identification of ACs at a higher risk for development of HAM/ TSP irrespective of the PVL level. However, longitudinal studies are still needed to answer this.
